期刊文献+

高剂量方案治疗复治肺结核疗效观察

Effect of high-dose regimen for the retreatment of tuberculosis
下载PDF
导出
摘要 目的探讨采用高剂量方案治疗复治菌阳肺结核患者的临床效果,为临床抗结核药物的科学使用提供依据。方法将复治菌阳肺结核患者91例随机分为两组,即高剂量组(4HL2+Lf X+EZ/4HL2E)和常规量组(2HRZES/6HRE)。治疗8个月后对两组患者痰菌阴转率、痰菌培养阳性率、病灶有效吸收率、空洞闭合率等进行比较分析。结果高剂量组患者菌阴转率、痰菌培养阳性率、病灶有效吸收率和空洞闭合率分别为95.6%、4.4%、84.4%、74.4%,明显优于常规量组患者的65.2%、21.7%、50.0%、52.5%,两组比较差异均有统计学意义(P<0.05)。结论使用高剂量方案治疗复治菌阳肺结核,临床效果好,安全性高,是可行的治疗方案。 Objective to investigate the clinical effect of high-dose regimen for the retreatment of tuberculosis, providing clinical evidence for the application of anti-tuberculosis drugs. Methods A total of 91 with pulmonary tuberculosis who underwent retreatment were randomly divided into high-dose group (4HL2 + LfX + EZ/4HL2E ) and regular-dose group (2HRZES/6HRE). After 8 months of treatment, sputum conversion rate, positive rate of sputum culture, focal absorption rate, and cavity closure rate between the two groups were compared. Results After treatment, the sputum conversion rate (95.6%), positive rate of sputum culture (4.4%), focal absorption rate (84.4%), and cavity closure rate (74.4%) of high-dose group were higher than those of regular-dose group which was 65.2% ,21.7%, 50.0%, and 52.5%, respectively. There was a significant difference between the two groups. Conclusions High-dose regimen has favorable outcomes in relapsing pulmonary tuberculosis, which is a safe and feasible theraputic approach.
作者 裴洁 银春莲
出处 《内科》 2015年第5期610-612,共3页 Internal Medicine
关键词 复治肺结核 高剂量 治疗 Pulmonary tuberculosis High-dose regimen Treatment
  • 相关文献

参考文献4

二级参考文献25

  • 1屠德华,张立兴.控制结核病传染源的步骤和方法的实践[J].中华结核和呼吸杂志,1993,16(4):241-241. 被引量:2
  • 2万利亚,池延花.世界银行贷款结核病控制项目实施情况分析与探讨[J].结核病与胸部肿瘤,1996(2):54-58. 被引量:38
  • 3万利亚,赵丰曾,池延花,邹级谦,戴元生,杜昕,王克文,李凤茹,苏智.世界银行贷款结核病控制项目实施情况分析与探讨[J].中国防痨杂志,1996,18(3):103-108. 被引量:125
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:1-8.
  • 5中华人民共和国卫生部.WS288-2008肺结核诊断标准.北京:人民卫生出版社,2008.
  • 6Johnson JL, Hadad DJ, Boom WH, et al. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis, 2006,10(6) :606-612.
  • 7World Health Organization. Guidelines for The Programmatic Management of Drug-Resistant Tuberculosis Emergency Up- date 2008 [ EB/OL]. WHO/HTM/TB/2008. 402. [ 2008- 0402] [ 2011-04-07]. http://www, who. int/tb/challenges/ mdr/programmatic guidelines for mdrtb/en/index. html.
  • 8中华人民共和国国家统计局.北京:中国统计年鉴2010.[M].中国统计出版社,2010.
  • 9中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 10中华人民共和国卫生部.2000年全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,2002.

共引文献5239

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部